The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026–2030
DOI:
https://doi.org/10.33321/cdi.2026.50.039Keywords:
Tuberculosis, Strategic PlanAbstract
The Strategic Plan for Tuberculosis Elimination and Equity in Australia, 2026-2030 provides the framework for Australia’s tuberculosis (TB) programmatic response over the next five years. The Strategic Plan upholds a focus on achieving TB elimination, and equitable outcomes for all people affected by TB.
Downloads
References
Trauer JM, Williams B, Laemmle-Ruff I, Horyniak D, Soares Caplice LV, McBryde ES et al. Tuberculosis in migrants to Australia: outcomes of a national screening program. Lancet Reg Health West Pac. 2021;10:100135. doi: https://doi.org/10.1016/j.lanwpc.2021.100135.
National Tuberculosis Advisory Committee (NTAC). The Strategic Plan for Control of Tuberculosis in Australia, 2021–2025. Commun Dis Intell (2018). 2022;46. doi: https://doi.org/10.33321/cdi.2022.46.48.
Donnan EJ, NTAC. Tuberculosis workforce policy and development framework in Australia. Commun Dis Intell (2018). 2025;49. doi: https://doi.org/10.33321/cdi.2025.49.009.
Australian Centre for Disease Control (Australian CDC), Communicable Diseases Network Authority (CDNA). Tuberculosis – CDNA National Guidelines for Public Health Units. [Webpage.] Canberra: Australian CDC; 1 March 2022. Available from: https://www.cdc.gov.au/resources/publications/cdna-national-guidelines-tuberculosis.
Gurjav U, Outhred AC, Jelfs P, McCallum N, Wang Q, Hill-Cawthorne GA et al. Whole genome sequencing demonstrates limited transmission within identified Mycobacterium tuberculosis clusters in New South Wales, Australia. PloS One. 2016;11(10):e0163612. doi: https://doi.org/10.1371/journal.pone.0163612.
NTAC. The Strategic Plan for Control of Tuberculosis in Australia, 2016–2020: Towards Disease Elimination. Commun Dis Intell (2018). 2019;43. doi: https://doi.org/10.33321/cdi.2019.43.10.
World Health Organization (WHO). Western Pacific regional framework to end TB: 2021–2030. Geneva: WHO; 2 March 2022. Available from: https://www.who.int/publications/i/item/9789290619703.
WHO. Towards tuberculosis elimination: an action framework in low-incidence countries. Geneva: WHO; 18 March 2014. Available from: https://www.who.int/publications/i/item/9789241507707.
Bright A, Denholm JT, Coulter C, Waring J, Stapledon R. Tuberculosis notifications in Australia, 2015–2018. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.88.
Laemmle-Ruff I, Graham SM, Williams B, Horyniak D, Majumdar SS, Paxton GA et al. Detecting Mycobacterium tuberculosis infection in children migrating to Australia. Emerg Infect Dis. 2022;28(9):1833–41. doi: https://doi.org/10.3201/eid2809.212426.
NTAC. Essential components of a tuberculosis control program within Australia. Commun Dis Intell Q Rep. 2014;38(4):E397–400. doi: https://doi.org/10.33321/cdi.2014.38.64.
Dale KD, Trauer JM, Dodd PJ, Houben RMGJ, Denholm JT. Estimating the prevalence of latent tuberculosis in a low-incidence setting: Australia. Eur Respir J. 2018;52(6):1801218. doi: https://doi.org/10.1183/13993003.01218-2018.
Donnan EJ, Marais BJ, Coulter C, Waring J, Bastian I, Williamson DA et al. The use of whole genome sequencing for tuberculosis public health activities in Australia: a joint statement of the National Tuberculosis Advisory Committee and Communicable Diseases Genomics Network. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.8.
Denholm J, Coulter C, Bastian I. Defining a tuberculosis cluster or outbreak. Commun Dis Intell Q Rep. 2016;40(3):E356–9. doi: https://doi.org/10.33321/cdi.2016.40.37.
Alffenaar JW, Akkerman OW, Kim HY, Tiberi S, Migliori GB. Precision and personalized medicine and anti-TB treatment: is TDM feasible for programmatic use? Int J Infect Dis. 2020;92:S5–9. doi: https://doi.org/10.1016/j.ijid.2020.01.041.
Stapledon R, Donnan EJ, NTAC. Australian recommendations for the management of drug-resistant tuberculosis, 2023. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.48.
Coorey NJ, Kensitt L, Davies J, Keller E, Sheel M, Chani K et al. Risk factors for TB in Australia and their association with delayed treatment completion. Int J Tuberc Lung Dis. 2022;26(5):399–405. doi: https://doi.org/10.5588/ijtld.21.0111.
Morton AJ, Roddy Mitchell A, Melville RE, Hui L, Tong SY, Dunstan SJ et al. Mycobacterium tuberculosis infection in pregnancy: a systematic review. PLoS Glob Public Health. 2024;4(11):0003578. doi: https://doi.org/10.1371/journal.pgph.0003578.
Garg RK, Malhotra HS, Suresh V, Garg R, Jain A, Gupta S et al. Tuberculosis following in vitro fertilization: a systematic review of case reports, case series, and cohort studies. medRxiv. 2024. doi: https://doi.org/10.1101/2024.10.20.24315846.
Menzies NA, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health. 2021;9(12):e1679–87. doi: https://doi.org/10.1016/S2214-109X(21)00367-3.
Published
How to Cite
License
Copyright (c) 2026 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
